JP2015500833A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015500833A5 JP2015500833A5 JP2014545985A JP2014545985A JP2015500833A5 JP 2015500833 A5 JP2015500833 A5 JP 2015500833A5 JP 2014545985 A JP2014545985 A JP 2014545985A JP 2014545985 A JP2014545985 A JP 2014545985A JP 2015500833 A5 JP2015500833 A5 JP 2015500833A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- compound
- composition
- hydrogen
- effective amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims description 27
- 150000003839 salts Chemical class 0.000 claims description 21
- 229910052739 hydrogen Inorganic materials 0.000 claims description 15
- 239000001257 hydrogen Substances 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 15
- 150000004712 monophosphates Chemical group 0.000 claims description 11
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 9
- 239000001177 diphosphate Substances 0.000 claims description 8
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims description 8
- 235000011180 diphosphates Nutrition 0.000 claims description 8
- 239000001226 triphosphate Substances 0.000 claims description 6
- 235000011178 triphosphate Nutrition 0.000 claims description 6
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 claims description 6
- 239000008194 pharmaceutical composition Substances 0.000 claims description 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 5
- 150000002431 hydrogen Chemical class 0.000 claims description 4
- 206010012335 Dependence Diseases 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 2
- 125000002264 triphosphate group Chemical group [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 claims description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 239000011593 sulfur Substances 0.000 claims 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 1
- -1 phosphate ester Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161569150P | 2011-12-09 | 2011-12-09 | |
| US61/569,150 | 2011-12-09 | ||
| PCT/US2012/067799 WO2013085922A1 (en) | 2011-12-09 | 2012-12-04 | Phosphate esters of noribogaine |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017161035A Division JP2017203047A (ja) | 2011-12-09 | 2017-08-24 | ノルイボガインのリン酸エステル |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015500833A JP2015500833A (ja) | 2015-01-08 |
| JP2015500833A5 true JP2015500833A5 (enExample) | 2016-01-28 |
Family
ID=48574807
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014545985A Pending JP2015500833A (ja) | 2011-12-09 | 2012-12-04 | ノルイボガインのリン酸エステル |
| JP2017161035A Pending JP2017203047A (ja) | 2011-12-09 | 2017-08-24 | ノルイボガインのリン酸エステル |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017161035A Pending JP2017203047A (ja) | 2011-12-09 | 2017-08-24 | ノルイボガインのリン酸エステル |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US9051343B2 (enExample) |
| EP (1) | EP2788003A4 (enExample) |
| JP (2) | JP2015500833A (enExample) |
| CA (1) | CA2855994A1 (enExample) |
| WO (1) | WO2013085922A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9394294B2 (en) | 2010-05-11 | 2016-07-19 | Demerx, Inc. | Methods and compositions for preparing and purifying noribogaine |
| US9586954B2 (en) | 2010-06-22 | 2017-03-07 | Demerx, Inc. | N-substituted noribogaine prodrugs |
| US8802832B2 (en) | 2010-06-22 | 2014-08-12 | Demerx, Inc. | Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier |
| JP6049615B2 (ja) | 2010-07-23 | 2016-12-21 | デマークス・インコーポレイテッドＤｅｍｅｒｘ，Ｉｎｃ． | ノリボガイン組成物 |
| EP2481740B1 (en) | 2011-01-26 | 2015-11-04 | DemeRx, Inc. | Methods and compositions for preparing noribogaine from voacangine |
| US9617274B1 (en) | 2011-08-26 | 2017-04-11 | Demerx, Inc. | Synthetic noribogaine |
| EP2788003A4 (en) * | 2011-12-09 | 2015-05-27 | Demerx Inc | PHOSPHATESTER OF NORIBOGAIN |
| CA2858820C (en) | 2012-01-25 | 2021-08-17 | Demerx, Inc. | Synthetic voacangine |
| CA2896133A1 (en) | 2012-12-20 | 2014-06-26 | Demerx, Inc. | Substituted noribogaine |
| US9045481B2 (en) | 2012-12-20 | 2015-06-02 | Demerx, Inc. | Substituted noribogaine |
| US8940728B2 (en) | 2012-12-20 | 2015-01-27 | Demerx, Inc. | Substituted noribogaine |
| CA2942638C (en) | 2013-03-15 | 2026-03-10 | Demerx, Inc. | Method for noribogaine treatment of addiction in patients on methadone |
| US9561232B2 (en) | 2014-02-18 | 2017-02-07 | Demerx, Inc. | Low dose noribogaine for treating nicotine addiction and preventing relapse of nicotine use |
| US9591978B2 (en) | 2014-03-13 | 2017-03-14 | Demerx, Inc. | Methods and compositions for pre-screening patients for treatment with noribogaine |
| CA2983727A1 (en) * | 2014-04-21 | 2015-10-29 | Demerx, Inc. | N-substituted noribogaine prodrugs |
| US9549935B2 (en) | 2014-07-14 | 2017-01-24 | Demerx, Inc. | Methods and compositions for treating migraines using noribogaine |
| ES2867174T3 (es) | 2014-11-26 | 2021-10-20 | Demerx Inc | Métodos y composiciones para potenciar la acción de analgésicos opioides mediante el uso de alcaloides de iboga |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| US12459965B2 (en) | 2017-10-09 | 2025-11-04 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
| CA3093301A1 (en) | 2018-03-08 | 2019-09-12 | New Atlas Biotechnologies Llc | Processes for the production of tryptamines |
| JP2022529781A (ja) | 2019-04-17 | 2022-06-24 | コンパス パスファインダー リミテッド | サイロシビンによるうつ病及び他の様々な障害の治療 |
| EP3747992A1 (en) | 2019-06-04 | 2020-12-09 | Medizinische Hochschule Hannover | Compositions and process for integrating cells into epithelium |
| WO2024145462A1 (en) * | 2022-12-29 | 2024-07-04 | Atai Therapeutics, Inc. | Ibogaine and noribogaine analogs and methods of use |
Family Cites Families (84)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2813873A (en) | 1957-11-19 | Derivatives of the ibogaine alkaloids | ||
| GB841697A (en) | 1956-03-22 | 1960-07-20 | Ciba Ltd | Analgesic compositions |
| GB924042A (en) | 1959-03-05 | 1963-04-18 | Geigy Ag J R | Process for the decarboxylation of alkyl esters of unsaturated, nitrogen-containing carboxylic acids |
| US3639408A (en) | 1967-06-03 | 1972-02-01 | Shionogi & Co | Process for the preparation of isoquinuclidine derivatives |
| US3516989A (en) | 1967-10-02 | 1970-06-23 | American Home Prod | Intermediates for total synthesis of iboga alkaloids and means of preparation |
| FR7131M (enExample) | 1968-01-31 | 1969-07-21 | ||
| US3574220A (en) | 1969-08-14 | 1971-04-06 | American Home Prod | 1,7-methano-1h-1-benzazepin-5(4h)-ones |
| US3557126A (en) | 1969-08-14 | 1971-01-19 | American Home Prod | Derivatives of iboga alkaloids |
| CA982478A (en) | 1971-04-12 | 1976-01-27 | Jerome Berk | Orally administered drug composition for therapy in the treatment of narcotic drug addiction |
| US4375414A (en) | 1971-05-20 | 1983-03-01 | Meir Strahilevitz | Immunological methods for removing species from the blood circulatory system and devices therefor |
| US3715361A (en) | 1971-10-08 | 1973-02-06 | American Cyanamid Co | Acyl derivatives of 10-methoxyibogamine |
| US3875011A (en) | 1972-11-06 | 1975-04-01 | Syva Co | Enzyme immunoassays with glucose-6-phosphate dehydrogenase |
| US4107288A (en) | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
| FR2296418B1 (enExample) | 1974-12-30 | 1978-07-21 | Anvar | |
| US4272541A (en) | 1978-06-02 | 1981-06-09 | Miles Laboratories, Inc. | 7,8 and 7-8 Substituted 4,5α-epoxymorphinan-6-one compounds, and methods of treating pain and drug dependence with them |
| US4464378A (en) | 1981-04-28 | 1984-08-07 | University Of Kentucky Research Foundation | Method of administering narcotic antagonists and analgesics and novel dosage forms containing same |
| CA1188989A (en) | 1981-05-21 | 1985-06-18 | Richard R. Scherschlicht | Nonapeptide for the treatment of drug withdrawal symptoms |
| US4604365A (en) | 1981-06-02 | 1986-08-05 | Electro-Nucleonics, Inc. | Immunoprecipitation assay |
| US4462941A (en) | 1982-06-10 | 1984-07-31 | The Regents Of The University Of California | Dynorphin amide analogs |
| US4499096A (en) | 1983-11-18 | 1985-02-12 | Lotsof Howard S | Rapid method for interrupting the narcotic addiction syndrome |
| US5266574A (en) | 1984-04-09 | 1993-11-30 | Ian S. Zagon | Growth regulation and related applications of opioid antagonists |
| US4626539A (en) | 1984-08-10 | 1986-12-02 | E. I. Dupont De Nemours And Company | Trandermal delivery of opioids |
| US4573995A (en) | 1984-10-09 | 1986-03-04 | Alza Corporation | Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine |
| GB8430346D0 (en) | 1984-11-30 | 1985-01-09 | Reckitt & Colmann Prod Ltd | Analgesic compositions |
| EP0186019B1 (de) | 1984-12-22 | 1993-10-06 | Schwarz Pharma Ag | Wirkstoffpflaster |
| US4806341A (en) | 1985-02-25 | 1989-02-21 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration |
| US4587243A (en) | 1985-07-15 | 1986-05-06 | Lotsof Howard S | Rapid method for interrupting the cocaine and amphetamine abuse syndrome |
| US5316759A (en) | 1986-03-17 | 1994-05-31 | Robert J. Schaap | Agonist-antagonist combination to reduce the use of nicotine and other drugs |
| US4904768A (en) * | 1987-08-04 | 1990-02-27 | Bristol-Myers Company | Epipodophyllotoxin glucoside 4'-phosphate derivatives |
| US4857523A (en) | 1988-07-18 | 1989-08-15 | Nda International, Inc. | Rapid method for attenuating the alcohol dependency syndrome |
| US5629307A (en) | 1989-10-20 | 1997-05-13 | Olney; John W. | Use of ibogaine in reducing excitotoxic brain damage |
| US5075341A (en) | 1989-12-01 | 1991-12-24 | The Mclean Hospital Corporation | Treatment for cocaine abuse |
| DE4010079A1 (de) | 1990-03-29 | 1991-10-02 | Lohmann Therapie Syst Lts | Pharmazeutische formulierung zur behandlung des alkoholismus |
| US5026697A (en) | 1990-05-30 | 1991-06-25 | Nda International, Inc. | Rapid method for interrupting or attenuating the nicotine/tobacco dependency syndrome |
| US5152994A (en) | 1990-05-31 | 1992-10-06 | Lotsof Howard S | Rapid method for interrupting or attenuating poly-drug dependency syndromes |
| US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| US5283247A (en) | 1991-02-06 | 1994-02-01 | Research Corporation Technologies, Inc. | Anticonvulsant substituted quinazolones |
| US5149538A (en) | 1991-06-14 | 1992-09-22 | Warner-Lambert Company | Misuse-resistive transdermal opioid dosage form |
| US5290784A (en) | 1991-07-18 | 1994-03-01 | Yueqian Qu | Aconitane derivatives used as a medication to treat addiction |
| DE69320646T2 (de) | 1992-04-10 | 1999-01-14 | Merrell Pharmaceuticals Inc., Cincinnati, Ohio | Verfahren zur behandlung von krebs durch kombinationstherapie mit 2'-halomethylidenderivaten und einem s- oder m-phase spezifischen antineoplastischen wirkstoff |
| WO1993025217A1 (en) | 1992-06-12 | 1993-12-23 | Des-Tyr Dynorphin Partnership | Des-tyr dynorphin analogues |
| US5256669A (en) | 1992-08-07 | 1993-10-26 | Aminotek Sciences, Inc. | Methods and compositions for treating acute or chronic pain and drug addiction |
| US5382657A (en) | 1992-08-26 | 1995-01-17 | Hoffmann-La Roche Inc. | Peg-interferon conjugates |
| US5580876A (en) | 1992-09-21 | 1996-12-03 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists |
| EP0668764A1 (en) | 1992-09-21 | 1995-08-30 | QIN, Bo-yi | Methods for identifying and using low/non-addictive opioid analgesics |
| CN1042895C (zh) | 1992-09-23 | 1999-04-14 | 曲曰谦 | 治疗吸毒者戒断综合症及脱瘾的药物组合物 |
| AU4066693A (en) | 1992-12-23 | 1994-07-19 | Bernhard Hugemann | Compacted drug body for use in the mechanical generation of inhalable active-substance particles |
| US5865444A (en) | 1994-03-21 | 1999-02-02 | Deere & Company | Body leveling suspension including a pivoting arrangement |
| JP2819236B2 (ja) | 1994-05-06 | 1998-10-30 | 日東電工株式会社 | 経皮吸収製剤 |
| US5552406A (en) | 1994-06-17 | 1996-09-03 | The Mclean Hospital Corporation | Method for treating pain and brain perfusion abnormalities using mixed opioid agonist-antagonists |
| ES2264562T3 (es) * | 1994-07-25 | 2007-01-01 | Nda International, Inc. | Uso de derivados de noribogaina para tratar la dependencia quimica en mamiferos. |
| US5591738A (en) | 1994-10-14 | 1997-01-07 | Nda International, Inc. | Method of treating chemical dependency using β-carboline alkaloids, derivatives and salts thereof |
| IL123220A0 (en) | 1995-08-08 | 1998-09-24 | Albany Medical College | Ibogamine congeners |
| US5760044A (en) | 1996-05-16 | 1998-06-02 | Archer; Sydney | Method for treating cocaine and amphetamine dependency |
| EP0912577A2 (en) | 1996-05-21 | 1999-05-06 | THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services | Novel methods of o-demethylation and n-deprotection |
| GB9702701D0 (en) * | 1997-02-01 | 1997-04-02 | Univ Newcastle Ventures Ltd | Quinazolinone compounds |
| ES2435722T3 (es) | 1997-09-04 | 2013-12-23 | Demerx, Inc. | Noribogaína en el tratamiento del dolor y de la adicción a drogas |
| US7220737B1 (en) | 1997-09-04 | 2007-05-22 | Novoneuron, Inc | Noribogaine in the treatment of pain and drug addiction |
| US6451806B2 (en) | 1999-09-29 | 2002-09-17 | Adolor Corporation | Methods and compositions involving opioids and antagonists thereof |
| KR100889718B1 (ko) | 2001-06-11 | 2009-03-23 | 바이오비트럼 에이비(피유비엘) | 치환 술폰아미드 화합물, ｃｎｓ 장애, 비만 및 ⅱ 형당뇨병 치료용 약제로서의 이들의 사용 방법 |
| US20030153552A1 (en) | 2002-02-14 | 2003-08-14 | Mash Deborah C. | Method of treating chemical dependency in mammals and a composition therefor |
| US6864271B2 (en) | 2002-11-12 | 2005-03-08 | The Foundation For The Lsu Health Sciences Center | Synergistic combinations including N-acylated 4-hydroxyphenylamine derivatives |
| US6806291B1 (en) | 2003-10-09 | 2004-10-19 | The Foundation For The Lsu Health Sciences Center | Analgesic compounds, their synthesis and pharmaceutical compositions containing them |
| WO2005049627A1 (en) * | 2003-11-18 | 2005-06-02 | Novogen Research Pty Ltd | Isoflavonoid prodrugs, compositions thereof and therapeutic methods involving same |
| US8017151B2 (en) | 2004-09-07 | 2011-09-13 | Board Of Regents Of The University Of Nebraska By And Behalf Of The University Of Nebraska Medical Center | Amphiphilic polymer-protein conjugates and methods of use thereof |
| ATE490237T1 (de) | 2005-08-26 | 2010-12-15 | Medical Res Council | Anionisch substituierte 7-nitroindol derivate und deren verwendung |
| WO2007062999A2 (en) | 2005-11-30 | 2007-06-07 | F. Hoffmann-La Roche Ag | 1,5-substituted indol-2-yl amide derivatives |
| EP1998766A2 (en) * | 2005-12-16 | 2008-12-10 | Ironwood Pharmaceuticals, Inc. | Useful indole compounds |
| CA2737031A1 (en) * | 2008-09-29 | 2010-04-01 | Abbott Laboratories | Indole and indoline derivatives and methods of use thereof |
| US9625475B2 (en) * | 2008-09-29 | 2017-04-18 | Abbvie Inc. | Indole and indoline derivatives and methods of use thereof |
| EP2470177B1 (en) * | 2009-08-27 | 2015-07-15 | Bionomics Limited | Combination therapy for treating proliferative diseases |
| US8362007B1 (en) * | 2010-05-11 | 2013-01-29 | Demerx, Inc. | Substituted noribogaine |
| US8765737B1 (en) | 2010-05-11 | 2014-07-01 | Demerx, Inc. | Methods and compositions for preparing and purifying noribogaine |
| US8637648B1 (en) | 2010-06-22 | 2014-01-28 | Demerx, Inc. | Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier |
| US8802832B2 (en) | 2010-06-22 | 2014-08-12 | Demerx, Inc. | Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier |
| US8741891B1 (en) * | 2010-06-22 | 2014-06-03 | Demerx, Inc. | N-substituted noribogaine prodrugs |
| JP6049615B2 (ja) | 2010-07-23 | 2016-12-21 | デマークス・インコーポレイテッドＤｅｍｅｒｘ，Ｉｎｃ． | ノリボガイン組成物 |
| EP2481740B1 (en) | 2011-01-26 | 2015-11-04 | DemeRx, Inc. | Methods and compositions for preparing noribogaine from voacangine |
| SG2014011811A (en) | 2011-09-15 | 2014-05-29 | Demerx Inc | Noribogaine salt ansolvates |
| EP2788003A4 (en) * | 2011-12-09 | 2015-05-27 | Demerx Inc | PHOSPHATESTER OF NORIBOGAIN |
| CA2896133A1 (en) * | 2012-12-20 | 2014-06-26 | Demerx, Inc. | Substituted noribogaine |
| US9045481B2 (en) | 2012-12-20 | 2015-06-02 | Demerx, Inc. | Substituted noribogaine |
| US8940728B2 (en) | 2012-12-20 | 2015-01-27 | Demerx, Inc. | Substituted noribogaine |
| US20150258104A1 (en) * | 2014-03-13 | 2015-09-17 | Demerx, Inc. | Use of noribogaine for the treatment of pain |
-
2012
- 2012-12-04 EP EP12854847.6A patent/EP2788003A4/en not_active Withdrawn
- 2012-12-04 WO PCT/US2012/067799 patent/WO2013085922A1/en not_active Ceased
- 2012-12-04 JP JP2014545985A patent/JP2015500833A/ja active Pending
- 2012-12-04 CA CA2855994A patent/CA2855994A1/en not_active Abandoned
- 2012-12-07 US US13/708,837 patent/US9051343B2/en active Active
-
2015
- 2015-05-29 US US14/726,399 patent/US20160115185A1/en not_active Abandoned
-
2017
- 2017-08-24 JP JP2017161035A patent/JP2017203047A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2581376A4 (en) | MATRIC ACID / MATRIN DERIVATIVES AND MANUFACTURING METHOD AND USES THEREOF | |
| CY1124882T1 (el) | Αναλογα 1,4-διϋποκατεστημενης πυριδαζινης και μεθοδοι για την θεραπευτικη αγωγη καταστασεων συναφων με ανεπαρκεια smn | |
| JP2013532652A5 (enExample) | ||
| JP2015509075A5 (enExample) | ||
| NZ631477A (en) | Substituted pyrrolidine-2-carboxamides | |
| SI3212174T1 (en) | Procedures for the treatment of infections with filoviridae virus | |
| JP2011037841A5 (enExample) | ||
| RU2011127079A (ru) | Комбинация производного циклоспорина и нуклеозидов для лечения инфекции вирусом гепатита с | |
| WO2015081133A3 (en) | Nucleotides for the treatment of liver cancer | |
| WO2011027249A3 (en) | Benzimidazole derivatives | |
| JP2012532136A5 (enExample) | ||
| EP2555622A4 (en) | HEPATITIS C-VIRUS HEMMER | |
| BR112013029692A2 (pt) | derivados de imidazol úteis para o tratamento da artrite | |
| WO2009082818A8 (en) | Novel c-21-keto lupane derivatives preparation and use thereof | |
| WO2017123884A8 (en) | Heterocyclic compounds as rsv inhibitors | |
| CY1117576T1 (el) | Δινουκλεοτιδικα προφαρμακα | |
| CY1122809T1 (el) | Εστερικα προ-φαρμακα της [3-(1-(1η-ιμιδαζολ-4-υλ)αιθυλο)-2-μεθυλοφαινυλο) μεθανολης για τη θεραπεια οφθαλμικων νοσηματων | |
| BR112015028501B8 (pt) | Compostos derivados de bipirazol, seus sais, composição compreendendo o composto ou o sal, método de inibição in vitro de uma atividade de jak1, e processo de preparação de sal de ácido fosfórico | |
| TN2016000090A1 (en) | Substituted quinolizine derivatives useful as hiv integrase inhibitors. | |
| MY148636A (en) | Benzimidazole derivatives | |
| EA201190099A1 (ru) | (1-фенил-2-пиридин-4-ил)этиловые эфиры бензойной кислоты в качестве ингибиторов фосфодиэстеразы | |
| CA2753382C (en) | Hepatitis c virus inhibitors | |
| NZ627274A (en) | Anesthetic compounds and related methods of use | |
| WO2014078295A8 (en) | Gemcitabine prodrugs and uses thereof | |
| BR112013028095A2 (pt) | inibidores de csf-1r para o tratamento de tumores cerebrais |